Hyperbaric oxygen therapy for perianal Crohn's disease.

Area of Science:

• Gastroenterology
• Surgical Innovation
• Oxygen Therapy

Background:

• Crohn's disease (CD) often presents complex gastrointestinal complications.
• Refractory ischemic ulcers at the ileorectal anastomosis are a challenging manifestation.
• Perianal Crohn's disease (PCD) significantly impacts patient quality of life.

Discussion:

• Hyperbaric oxygen therapy (HBOT) has demonstrated effectiveness in managing refractory ischemic ulcers in CD.
• HBOT offers a potential therapeutic avenue for perianal Crohn's disease (PCD).
• Sharing clinical experiences and reviewing recent trials are crucial for understanding HBOT's role.

Key Insights:

• Successful long-term outcomes have been reported with HBOT for specific CD-related ulcers.
• HBOT may provide a non-invasive treatment option for debilitating PCD.
• Further research and clinical data are needed to fully establish HBOT protocols for CD.

Outlook:

• Continued investigation into HBOT for various manifestations of Crohn's disease is warranted.
• Exploring HBOT's mechanisms of action in inflammatory bowel disease could reveal new therapeutic targets.
• Standardization of HBOT protocols for CD patients will enhance its clinical applicability.